Difference between revisions of "Antiphospholipid antibody syndrome"
Jump to navigation
Jump to search
(create) |
(more) |
||
| Line 1: | Line 1: | ||
'''Antiphospholipid antibody syndrome''', also '''antiphospholipid syndrome''', is a thingy commonly seen in the context of [[systemic lupus erythematosus]].<ref name=pmid9814675>{{Cite journal | last1 = Asherson | first1 = RA. | title = The catastrophic antiphospholipid syndrome, 1998. A review of the clinical features, possible pathogenesis and treatment. | journal = Lupus | volume = 7 Suppl 2 | issue = | pages = S55-62 | month = | year = 1998 | doi = | PMID = 9814675 }}</ref> It is commonly abbreviated '''APLA'''. | '''Antiphospholipid antibody syndrome''', also '''antiphospholipid syndrome''', is a thingy commonly seen in the context of [[systemic lupus erythematosus]].<ref name=pmid9814675>{{Cite journal | last1 = Asherson | first1 = RA. | title = The catastrophic antiphospholipid syndrome, 1998. A review of the clinical features, possible pathogenesis and treatment. | journal = Lupus | volume = 7 Suppl 2 | issue = | pages = S55-62 | month = | year = 1998 | doi = | PMID = 9814675 }}</ref> It is commonly abbreviated '''APLA'''. | ||
==General== | |||
Hypercoagulable state. | |||
*See: ''[[Pulmonary_embolism#Risks_factors_.28VTE.29|Pulmonary embolism risk factors]]'' for the [[DDx]]. | |||
==Microscopic== | ==Microscopic== | ||
:See: ''[[Thrombotic microangiopathy#Microscopic| | :See: ''[[Thrombotic microangiopathy#Microscopic|Thrombotic microangiopathy]]''. | ||
==See also== | ==See also== | ||
Latest revision as of 16:46, 4 December 2011
Antiphospholipid antibody syndrome, also antiphospholipid syndrome, is a thingy commonly seen in the context of systemic lupus erythematosus.[1] It is commonly abbreviated APLA.
General
Hypercoagulable state.
- See: Pulmonary embolism risk factors for the DDx.